Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tilman Todenhöfer
Observed name:
T. Todenhöfer
Institution:
Praxis für Humangenetik Tübingen
Observed institutions:
Universitätsklinikum Tübingen,
Praxis für Humangenetik Tübingen,
Vancouver Prostate Centre,
University of Tübingen
ORCID:
0000-0002-8319-5602
Observed ORCID:
0000-0002-8319-5602
OpenAlex ID:
A5103164930
Liquid biopsy: ready to guide therapy in advanced prostate cancer?
2016
·
Miriam Hegemann
, Arnulf Stenzl
, et al.
·
British Journal of Urology
·
70
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis–targeting Agents in Metastatic Castration-resistant Prostate Cancer
2018
·
Sarah Q. To
, Edmond M. Kwan
, et al.
·
European Urology
·
46
Circulating tumor cells and their role in prostate cancer
2019
·
Arnulf Stenzl
, Moritz Maas
, et al.
·
Asian Journal of Andrology
·
25
Expression of tumour progression‐associated genes in circulating tumour cells of patients at different stages of prostate cancer
2018
·
Giorgio I. Russo
, Simone Bier
, et al.
·
British Journal of Urology
·
24
Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer
2019
·
Edmond M. Kwan
, Heidi Fettke
, et al.
·
European Urology Focus
·
16
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer
2022
·
Katharina Besler
, Aleksandra Węglarz
, et al.
·
Clinical Chemistry
·
5
PDF
Pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with docetaxel-pretreated, metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort E.
2024
·
Marinela Augustin
, Brigitte Laguerre
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Aktuelle leitliniengerechte Nachsorge kleiner Nierentumoren: Angewandte Risikoscores und Zukunftsausblick
2018
·
V. Stühler
, S. Kruck
, et al.
·
Der Urologe
·
2
Aktuelles zur Liquid Biopsy bei urologischen Tumoren
2017
·
Tilman Todenhöfer
·
Uro-News
·
1
Correlation of AR-V7 expression in whole blood with efficacy of abiraterone acetate (ABI) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).
2016
·
Arun Azad
, Tilman Todenhöfer
, et al.
·
Journal of Clinical Oncology
·
1
Adjuvante Phase-III-Studie für Patienten mit lokal fortgeschrittenem oder metastasiertem kastrationsresistenten Prostatakarzinom (laPC/mHSPC)
2023
·
Heidrun Rexer
, Tilman Todenhöfer
, et al.
·
Forum
Chemotherapie schlägt neue hormonelle Therapie: Optimale Therapiesequenz nach Versagen von Abirateron oder Enzalutamid
2020
·
Tilman Todenhöfer
·
Der Urologe
Correlation of a whole blood RNA assay detecting AR-v7 expression with PSA response in patients with metastatic castration-resistant prostate cancer (mCRPC)
2017
·
E. Kwan
, S. To
, et al.
·
Annals of Oncology
Mp87-06 Expression Analysis of Tumor Promoting Genes in Circulating Tumor Cells of Patients With Localized and Metastatic Prostate Cancer
2017
·
Simone Bier
, Jörg Hennenlotter
, et al.
·
The Journal of Urology
Erratum
2016
·
Jochen Hess
, Yasmine Hess-Busch
, et al.
·
Urologia Internationalis
PDF
Krebsvorsorge - Prostatakarzinom
2013
·
Johannes Mischinger
, Jens Bedke
, et al.
·
Lege artis - Das Magazin zur ärztlichen Weiterbildung
Show more works
View as search
Works count:
16
Citation count:
192
H-index:
5
I10-index:
5
Year
Topic
Type
